FDA’s Latest PR Push: Protecting the Reputation of Generic Drugs
This article was originally published in RPM Report
The public’s acceptance of generic drugs is at an all-time high. But manufacturing issues, shortages of life-saving medications and questions about the overall quality of generics are testing the system like never before. FDA’s tough love message to industry: fix the manufacturing problems—or risk your reputation.